MIRA Pharmaceuticals, Inc.
MIRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$22,694 | -$1,538 | -$1,784 | -$2,400 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $490 | $0 | $547 |
| Change in WC | -$174 | $248 | -$721 | $48 |
| Other Non-Cash | $21,772 | $0 | $875 | $0 |
| Operating Cash Flow | -$1,097 | -$800 | -$1,630 | -$1,805 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $14 |
| Stock Issued | $3,008 | $324 | $3 | $479 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $3,008 | $324 | $3 | $493 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,911 | -$476 | -$1,627 | -$1,312 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $730 | $1,206 | $2,833 | $4,145 |
| End Cash | $2,642 | $730 | $1,206 | $2,833 |
| Free Cash Flow | -$1,097 | -$800 | -$1,630 | -$1,805 |